2021 AHA科学声明:下肢外周动脉疾病:当代流行病学、管理差距和未来方向

2021-07-28 美国心脏协会 Circulation . 2021 Jul 28

下肢外周动脉疾病(PAD)影响着全球2.3亿成年人,与各种不良临床结果(其他心血管疾病如冠心病和中风以及腿部结果如截肢)的风险增加有关。尽管PAD很普遍且具有临床重要性,但历来没有得到医护人员和患者的

中文标题:

2021 AHA科学声明:下肢外周动脉疾病:当代流行病学、管理差距和未来方向

英文标题:

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

发布机构:

美国心脏协会

发布日期:

2021-07-28

简要介绍:

下肢外周动脉疾病(PAD)影响着全球2.3亿成年人,与各种不良临床结果(其他心血管疾病如冠心病和中风以及腿部结果如截肢)的风险增加有关。尽管PAD很普遍且具有临床重要性,但历来没有得到医护人员和患者的重视。这种不重视似乎是多因素造成的(例如,一线诊断测试--踝臂指数在诊所的可用性有限;错误地认为腿部血管疾病不是致命的,诊断PAD不一定会改变临床实践)。在过去的几年里,大量的证据表明,这些看法是不正确的。一些研究一直表明,许多PAD患者没有接受循证治疗。因此,本科学声明为医护人员提供了关于PAD的当代流行病学(如流行率、时间趋势、风险因素和并发症)、诊断的现状(生理测试和成像方式)以及PAD管理的主要差距(如药物、运动疗法和血管再造)的最新情况。该声明还列出了与PAD相关的研究、临床实践和实施方面的主要差距。为了提高对PAD的认识和理解,改善PAD的诊断方法、管理和预后,需要不同方面(如医疗服务提供者、研究人员、专家组织和医疗机构)的协调努力。

相关资料下载:
[AttachmentFileName(sort=1, fileName=下肢外周动脉疾病,.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a891f1c002150540, title=2021 AHA科学声明:下肢外周动脉疾病:当代流行病学、管理差距和未来方向, enTitle=Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association, guiderFrom=Circulation . 2021 Jul 28, authorId=0, author=, summary=下肢外周动脉疾病(PAD)影响着全球2.3亿成年人,与各种不良临床结果(其他心血管疾病如冠心病和中风以及腿部结果如截肢)的风险增加有关。尽管PAD很普遍且具有临床重要性,但历来没有得到医护人员和患者的, cover=https://img.medsci.cn/202184/1628091153139_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Wed Jul 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>下肢外周动脉疾病(PAD)影响着全球2.3亿成年人,与各种不良临床结果(其他心血管疾病如冠心病和中风以及腿部结果如截肢)的风险增加有关。尽管PAD很普遍且具有临床重要性,但历来没有得到医护人员和患者的重视。这种不重视似乎是多因素造成的(例如,一线诊断测试--踝臂指数在诊所的可用性有限;错误地认为腿部血管疾病不是致命的,诊断PAD不一定会改变临床实践)。在过去的几年里,大量的证据表明,这些看法是不正确的。一些研究一直表明,许多PAD患者没有接受循证治疗。因此,本科学声明为医护人员提供了关于PAD的当代流行病学(如流行率、时间趋势、风险因素和并发症)、诊断的现状(生理测试和成像方式)以及PAD管理的主要差距(如药物、运动疗法和血管再造)的最新情况。该声明还列出了与PAD相关的研究、临床实践和实施方面的主要差距。为了提高对PAD的认识和理解,改善PAD的诊断方法、管理和预后,需要不同方面(如医疗服务提供者、研究人员、专家组织和医疗机构)的协调努力。</p>, tagList=[TagDto(tagId=6195, tagName=外周动脉疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=45582, guiderKeyword=下肢外周动脉疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14986, appHits=159, showAppHits=0, pcHits=1345, showPcHits=14826, likes=0, shares=8, comments=5, approvalStatus=1, publishedTime=Thu Aug 05 07:44:56 CST 2021, publishedTimeString=2021-07-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Aug 04 23:32:41 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 20:13:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=下肢外周动脉疾病,.pdf)])
下肢外周动脉疾病,.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-09-18 12366zhang

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-18 ms1000000675463573

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-18 28347049

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 12393b88m65暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1052910, encodeId=b22b105291073, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12366zhang, createdTime=Sat Sep 18 22:44:41 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009147, encodeId=4c6c100914edd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af5d5469796, createdName=ms1000000675463573, createdTime=Wed Aug 18 15:29:37 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009129, encodeId=81eb100912963, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c48a5011520, createdName=28347049, createdTime=Wed Aug 18 15:26:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007098, encodeId=b795100e09806, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:26:06 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007103, encodeId=2b6a100e103c5, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/d398e6e90b1e43bab019dfb6106de8a1/9c8931ddfb274af1882d58a10b609e0f.jpg, createdBy=55d82419884, createdName=12393b88m65暂无昵称, createdTime=Wed Aug 11 22:36:15 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 12393b88m65暂无昵称

    学习了

    0